Related references
Note: Only part of the references are listed.Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Isolated from Australian Veterinarians
Mitchell D. Groves et al.
PLOS ONE (2016)
Multicenter study of health care cost of patients admitted to hospital with Staphylococcus aureus bacteremia: Impact of length of stay and intensity of care
Nisha Thampi et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2015)
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children
Liset Olarte et al.
CLINICAL INFECTIOUS DISEASES (2015)
Liposomal Formulation Decreases Toxicity of Amphotericin B In Vitro and In Vivo
Justin Roberts et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2015)
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition
Christopher J. L. Murray et al.
LANCET (2015)
A new antibiotic kills pathogens without detectable resistance
Losee L. Ling et al.
NATURE (2015)
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
David Brown
NATURE REVIEWS DRUG DISCOVERY (2015)
Prevalence of Parental Misconceptions About Antibiotic Use
Louise Elaine Vaz et al.
PEDIATRICS (2015)
Investigational Agents for the Treatment of Gram-Negative Bacterial Infections: A Reality Check
Karen Bush
ACS INFECTIOUS DISEASES (2015)
Community-associated methicillin-resistant Staphylococcus aureus transmission in households of infected cases: a pooled analysis of primary data from three studies across international settings
J. Knox et al.
EPIDEMIOLOGY AND INFECTION (2015)
Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial
Arto A. Palmu et al.
LANCET INFECTIOUS DISEASES (2014)
Incremental Health Care Utilization and Costs for Acute Otitis Media in Children
Sameer Ahmed et al.
LARYNGOSCOPE (2014)
Synergistic interactions in two-drug and three-drug combinations (thymol, EDTA and vancomycin) against multi drug resistant bacteria including E. coli
Razan Hamoud et al.
PHYTOMEDICINE (2014)
Increased EMRSA-15 health-care worker colonization demonstrated in retrospective review of EMRSA hospital outbreaks
Julie Hart et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2014)
Antibiotics in the clinical pipeline in 2013
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2013)
Call for global action to halt the superbug
Abdul Ghafur
MEDICAL JOURNAL OF AUSTRALIA (2013)
Crisis in Hospital-Acquired, Healthcare-Associated Infections
David P. Calfee
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
The adaptive potential during nasopharyngeal colonisation of Streptococcus pneumoniae
Marcus H. Y. Leung et al.
INFECTION GENETICS AND EVOLUTION (2011)
Serotype replacement in disease after pneumococcal vaccination
Daniel M. Weinberger et al.
LANCET (2011)
Scientific Opinion on safety and efficacy of Cycostat® 66G (robenidine hydrochloride) for rabbits for breeding and fattening EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
Gabriele Aquilina et al.
EFSA JOURNAL (2011)
Efficacy Profiles of Daptomycin for Treatment of Invasive and Noninvasive Pulmonary Infections with Streptococcus pneumoniae
Stefanie Henken et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
David N. Gilbert et al.
CLINICAL INFECTIOUS DISEASES (2010)
Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
Michael Z. David et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Building a Tiered Approach to In Vitro Predictive Toxicity Screening: A Focus on Assays with In Vivo Relevance
James M. McKim
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2010)
Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for Prevention
Joseph P. Lynch et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates
Ronald N. Jones et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus
Nicole Cotroneo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease
Layla K. Mahdi et al.
INFECTION AND IMMUNITY (2008)
In vitro and in vivo antibacterial activities of DC-159a, a new fluoroquinolone
Kazuki Hoshino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model
Abiodun D. Ogunniyi et al.
INFECTION AND IMMUNITY (2007)
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus
DL Higgins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
An ABC transporter with a secondary-active multidrug translocator domain
H Venter et al.
NATURE (2003)
Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus
JA Silverman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins
AM Berry et al.
INFECTION AND IMMUNITY (2000)
Share Paper
